# IASLC Grading System as a Predictor for EGFR-TKI Therapy

> **NCT06131645** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 2160 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** IASLC grading system

## Key facts

- **NCT ID:** NCT06131645
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-07-01
- **Target enrollment:** 2160 (ACTUAL)
- **Last updated:** 2023-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06131645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06131645, "IASLC Grading System as a Predictor for EGFR-TKI Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06131645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*